| A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Pa | Phase II | rekrutiert |
| A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients | Phase III | rekrutiert |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Mi | Phase III | rekrutiert |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic M | Phase III | rekrutiert |
| A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridemen | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis | Phase II | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Diseas | Phase II | rekrutiert |
| A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Synd | Phase III | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With | ohne Phasenangabe | rekrutiert |
| A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severe | Phase III | rekrutiert |
| A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in Pe | Phase II | rekrutiert |
| A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function | Phase II | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carbopla | Phase III | rekrutiert |
| A Study With CIT-013 in HS Patients | Phase II | rekrutiert |
| A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glu | — | rekrutiert |
| A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell | Phase I / Phase II | rekrutiert |
| A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagn | Phase III | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulce | Phase II | rekrutiert |
| A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Cro | Phase III | rekrutiert |
| A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refra | Phase I | rekrutiert |
| A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Phase II / Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapse | Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Co | Phase II | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Pati | Phase III | rekrutiert |
| A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease | Phase III | rekrutiert |
| A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemot | Phase III | rekrutiert |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Particip | Phase II | rekrutiert |
| A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia | — | rekrutiert |
| A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP | Phase III | rekrutiert |
| A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa | Phase II | rekrutiert |
| A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Aga | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Parti | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients W | Phase II | rekrutiert |
| A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migrai | Phase II | rekrutiert |
| A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bort | Phase III | rekrutiert |
| A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in P | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplant | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Ol | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moder | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previous | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease | Phase II | rekrutiert |
| A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adul | Phase III | rekrutiert |
| A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotocl | Phase III | rekrutiert |
| A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in | Phase I / Phase II | rekrutiert |
| A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerativ | Phase II | rekrutiert |
| A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sep | Phase II | rekrutiert |
| A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Part | Phase II | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Phase II | rekrutiert |
| A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People W | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Fa | Phase III | rekrutiert |
| A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part | Phase III | rekrutiert |
| A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rit | Phase III | rekrutiert |
| A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Ri | Phase III | rekrutiert |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Phase I / Phase II | rekrutiert |
| Abbott Vascular Medical Device Registry | — | rekrutiert |
| Abiomed Impella RT-DAQ - Observational Study | — | rekrutiert |
| Ablation of Consecutive Atrial Tachycardia | ohne Phasenangabe | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG | Phase III | rekrutiert |
| Asciminib Roll-over Study | Phase IV | rekrutiert |
| Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIA | — | rekrutiert |
| Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseContr | ohne Phasenangabe | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET) | — | rekrutiert |
| Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa | Phase II | rekrutiert |
| CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitu | Phase III | rekrutiert |
| COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Heal | — | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phas | — | rekrutiert |
| Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Syman | ohne Phasenangabe | rekrutiert |
| Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for t | ohne Phasenangabe | rekrutiert |
| Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and | — | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ES | Phase II / Phase III | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Determinants of Chronic Inflammatory Skin Disease Trajectories | — | rekrutiert |
| Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis | — | rekrutiert |
| Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis | Phase II | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EMBRACE Tremor BiFUS | ohne Phasenangabe | rekrutiert |
| EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn | ohne Phasenangabe | rekrutiert |
| Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease | Phase II | rekrutiert |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients W | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Pred | Phase II | rekrutiert |
| Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study | Phase III | rekrutiert |
| Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring S | Phase III | rekrutiert |
| Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment with or Without Sonrotoclax for | Phase II | rekrutiert |
| Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock | ohne Phasenangabe | rekrutiert |
| Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patie | Phase IV | rekrutiert |
| Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia | Phase II | rekrutiert |
| Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Pat | Phase III | rekrutiert |
| Follitropin Delta in Long GnRH-agonist Protocol | — | rekrutiert |
| Fosfomycin I.v. for Treatment of Severely Infected Patients | — | rekrutiert |
| Functional MRI for Monitoring Progression and Assessing Trends in ILD | ohne Phasenangabe | rekrutiert |
| GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 | Phase II | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German-funded Laparoscopic Approach to Cervical Cancer | ohne Phasenangabe | rekrutiert |
| Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III) | ohne Phasenangabe | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| Impact of Beta-blocker on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replaceme | ohne Phasenangabe | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Improvement of Quality of Life by Cannabinoids in Oncologic Patients | Phase II | rekrutiert |
| Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease | — | rekrutiert |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phen | Phase III | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patie | Phase II | rekrutiert |
| Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cel | Phase II | rekrutiert |
| L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) | Phase II | rekrutiert |
| L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma | Phase II | rekrutiert |
| L19IL2/TNF in Patients With Basal Cell Carcinoma | Phase II | rekrutiert |
| LEOPARD Prospective Validation Cohort 1 | — | rekrutiert |
| LEOPARD Training and Validation Data Collection Study | — | rekrutiert |
| LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus | ohne Phasenangabe | rekrutiert |
| Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdi | — | rekrutiert |
| Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRA | Phase III | rekrutiert |
| Long-term Follow-up of Children Born in the PETN Studies | — | rekrutiert |
| MiCLASP Post Market Clinical Follow-Up (PMCF) Study | — | rekrutiert |
| Molecular Signatures in Inflammatory Skin Disease | — | rekrutiert |
| Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory M | Phase III | rekrutiert |
| NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometr | — | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cance | Phase III | rekrutiert |
| Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Compl | Phase II | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Pan Tumor Rollover Study | Phase II | rekrutiert |
| Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothel | Phase II / Phase III | rekrutiert |
| Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for | Phase III | rekrutiert |
| Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanc | Phase III | rekrutiert |
| Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Phase III | rekrutiert |
| Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia | — | rekrutiert |
| Post-Market Clinical Follow Up Study With Navitor Valve | — | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study | — | rekrutiert |
| Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation | Phase II | rekrutiert |
| Prospective, Non-interventional Single-arm Study With Tezepelumab to Investigate the Change in C | — | rekrutiert |
| RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | ohne Phasenangabe | rekrutiert |
| REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Fa | — | rekrutiert |
| Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care A | Phase III | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real World Data Collection on the INSPIRIS RESILIA Aortic Valve | — | rekrutiert |
| Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wi | — | rekrutiert |
| Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodul | — | rekrutiert |
| Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy | Phase II | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry | — | rekrutiert |
| Revealing Microbiome Association With (Plant-based) Diet in Freshman | — | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| STIMPulseControl Ancillary Speech Study | ohne Phasenangabe | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Phase III | rekrutiert |
| Safe and Timely Antithrombotic Removal (STAR) Registry | — | rekrutiert |
| Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Ac | ohne Phasenangabe | rekrutiert |
| Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Ther | Phase II / Phase III | rekrutiert |
| Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor | Phase III | rekrutiert |
| Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis | Phase III | rekrutiert |
| Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy | — | rekrutiert |
| SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate | — | rekrutiert |
| Steps Against the Burden of Parkinson's Disease - RCT Kiel | ohne Phasenangabe | rekrutiert |
| Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-sm | Phase II / Phase III | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Wh | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Croh | Phase II | rekrutiert |
| Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative C | Phase II | rekrutiert |
| Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenou | Phase II | rekrutiert |
| Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With | — | rekrutiert |
| Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma | Phase I / Phase II | rekrutiert |
| Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disea | Phase III | rekrutiert |
| Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With P | Phase III | rekrutiert |
| T-cell Therapy in Patients With PML | Phase II | rekrutiert |
| TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Derm | — | rekrutiert |
| Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemi | Phase I / Phase II | rekrutiert |
| Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-A | Phase III | rekrutiert |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | Phase III | rekrutiert |
| The CATALINA Study | — | rekrutiert |
| Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells V | Phase III | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable | ohne Phasenangabe | rekrutiert |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephali | Phase II | rekrutiert |
| VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease | Phase IV | rekrutiert |
| VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti- | Phase III | rekrutiert |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed | Phase II | rekrutiert |
| Vercise™ DBS Dystonia Prospective Study | — | rekrutiert |
| Video-supervised Motor and Awareness Training in Writer's Cramp | Phase II | rekrutiert |
| Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established | Phase III | rekrutiert |